Khadra Galaal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Khadra Galaal has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Alberto Lopes
Joint BioEnergy Institute (JBEI), Emeryville, CA (United States); Univ. of Campinas (UNICAMP), Sao Paulo (Brazil)
8 shared publications Ruud Bekkers
Obstetrics and Gynaecology, Radboud UMC, Nijmegen, The Netherlands
8 shared publicationsAnke Smits
Gynaecological Oncology, Royal Cornwall Hospital Trust, Truro, UK
7 shared publicationsNagindra Das
Department of Gynaecology, Royal Cornwall Hospital Trust, Truro, Cornwall, UK
7 shared publicationsLeon Massuger
Obstetrics and Gynaecology, Radboud UMC, Nijmegen, The Netherlands
5 shared publicationsAndrew Bryant
Newcastle University
4 shared publications
Latest Publications
- 18 April 2016
- Published by Taylor & Francis in Expert Review of Quality of Life in Cancer Care
- Vol. 1 (3) , 221-229
Body mass index and outcomes of endometrial and ovarian cancer patients
Endometrial cancer and ovarian cancer are the most common gynaecological cancers in the developed world and are known to be associated with obesity. The escalating obesity epidemic in countries such as the United Kingdom has resulted in the majority of these patients being overweight or obese. Despite studies reporting on adverse effects of obesity throughout endometrial and ovarian cancer treatment and survivorship, a comprehensive overview is still unavailable. Given the fact gynaecological oncologists increasingly treat women within the obese, morbidly obese and even super obese classifications, it is essential to develop appropriate guidelines for clinical care. Through an analysis of the existing literature, we present a review of the current knowledge of the effect of body mass index on outcomes of endometrial and ovarian cancer patients, including treatment outcomes, quality of life and survival.
- 18 April 2016
- Published by Taylor & Francis in Expert Review of Quality of Life in Cancer Care
- Vol. 1 (3) , 221-229
Body mass index and outcomes of endometrial and ovarian cancer patients
Endometrial cancer and ovarian cancer are the most common gynaecological cancers in the developed world and are known to be associated with obesity. The escalating obesity epidemic in countries such as the United Kingdom has resulted in the majority of these patients being overweight or obese. Despite studies reporting on adverse effects of obesity throughout endometrial and ovarian cancer treatment and survivorship, a comprehensive overview is still unavailable. Given the fact gynaecological oncologists increasingly treat women within the obese, morbidly obese and even super obese classifications, it is essential to develop appropriate guidelines for clinical care. Through an analysis of the existing literature, we present a review of the current knowledge of the effect of body mass index on outcomes of endometrial and ovarian cancer patients, including treatment outcomes, quality of life and survival.
- Open Access
Exercise Programme in Endometrial Cancer; Protocol of the Feasibility and Acceptability Survivorship Trial (EPEC-FAST)
Introduction Obesity has been associated with impaired quality of life and poorer outcomes in endometrial cancer survivors. Lifestyle interventions promoting exercise and weight reduction have been proposed for survivorship care. However, studies evaluating exercise programmes for endometrial cancer survivors are lacking. Purpose The objective of this study is to evaluate the feasibility of an individualised exercise intervention for endometrial cancer survivors to improve quality of life. Methods and analysis This is a feasibility study in which women will undergo a 10-week exercise programme with a personal trainer. The study population comprises women with confirmed diagnosis of endometrial cancer, who have completed surgical treatment with curative intent, and are aged 18 years or older. The study will take place at the Royal Cornwall Hospital Trust, UK. Feasibility will be evaluated in terms of recruitment, adherence and compliance to the programme. Secondary outcomes are quality of life, psychological distress, fatigue, pain and complication rates. In addition, the acceptability of the programme will be assessed. Ethics and dissemination Ethical approval was obtained through the Exeter NRES Committee. The study results will be used to optimise the intervention content, and may serve as the foundation for a larger definitive trial. Results will be disseminated through peer-review journals, congresses, relevant clinical groups and presented on the Trust's website. Trial registration number: NCT02367950; pre-results.
Open AccessExercise Programme in Endometrial Cancer; Protocol of the Feasibility and Acceptability Survivorship Trial (EPEC-FAST)
Introduction Obesity has been associated with impaired quality of life and poorer outcomes in endometrial cancer survivors. Lifestyle interventions promoting exercise and weight reduction have been proposed for survivorship care. However, studies evaluating exercise programmes for endometrial cancer survivors are lacking. Purpose The objective of this study is to evaluate the feasibility of an individualised exercise intervention for endometrial cancer survivors to improve quality of life. Methods and analysis This is a feasibility study in which women will undergo a 10-week exercise programme with a personal trainer. The study population comprises women with confirmed diagnosis of endometrial cancer, who have completed surgical treatment with curative intent, and are aged 18 years or older. The study will take place at the Royal Cornwall Hospital Trust, UK. Feasibility will be evaluated in terms of recruitment, adherence and compliance to the programme. Secondary outcomes are quality of life, psychological distress, fatigue, pain and complication rates. In addition, the acceptability of the programme will be assessed. Ethics and dissemination Ethical approval was obtained through the Exeter NRES Committee. The study results will be used to optimise the intervention content, and may serve as the foundation for a larger definitive trial. Results will be disseminated through peer-review journals, congresses, relevant clinical groups and presented on the Trust's website. Trial registration number: NCT02367950; pre-results.
- 1 December 2015
- Published by Elsevier in Gynecologic Oncology
- Vol. 139 (3) , 546-552
The effect of lifestyle interventions on the quality of life of gynaecological cancer survivors
- 1 December 2015
- Published by Elsevier in Gynecologic Oncology
- Vol. 139 (3) , 546-552
The effect of lifestyle interventions on the quality of life of gynaecological cancer survivors
- 1 November 2015
- Published by Elsevier in Gynecologic Oncology
- Vol. 139 (2) , 369-376
The impact of BMI on surgical complications and outcomes in endometrial cancer surgery—An institutional study and systematic review of the literature
- 1 November 2015
- Published by Elsevier in Gynecologic Oncology
- Vol. 139 (2) , 369-376
The impact of BMI on surgical complications and outcomes in endometrial cancer surgery—An institutional study and systematic review of the literature
- 1 October 2015
- Published by Elsevier in Gynecologic Oncology
- Vol. 139 (1) , 148-154
Body mass index, physical activity and quality of life of ovarian cancer survivors: Time to get moving?
- 1 October 2015
- Published by Elsevier in Gynecologic Oncology
- Vol. 139 (1) , 148-154
Body mass index, physical activity and quality of life of ovarian cancer survivors: Time to get moving?
- 2 September 2015
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 123 (2) , 300-308
Surgical morbidity and clinical outcomes in ovarian cancer – the role of obesity
Objective: To evaluate the effect of body mass index on the surgical outcomes in ovarian cancer patients. In addition, we performed a systematic review to compare our outcomes with the current literature.Design: Retrospective cohort study and a systematic review of the literature.Setting: Gynaecology department at the Royal Cornwall Hospital Trust.Population: Surgically managed stage I‐IV ovarian cancer patients between September 2006 and September 2014.Methods: Primary and secondary outcome measures were evaluated across BMI categories; BMI <25 kg/m², BMI 25–29.9 kg/m², BMI ≥30 kg/m² and BMI ≥40 kg/m². A systematic review was performed according to Preferred Reporting Items for Systematic reviews and Meta‐Analyses (PRISMA) guidelines.Main outcome measures: The primary outcome measure was surgical complications. Secondary outcome measures were other intra‐ and postoperative outcomes.Results: Two hundred twenty‐eight women were included in the study, of which 84 had a BMI <25 kg/m², 84 women had a BMI 25–29.9 kg/m², and 60 women were obese (BMI ≥30 kg/m²), 13 of whom were morbidly obese. Morbid obesity was associated with increased rates of wound complications. However, BMI did not show an association with other outcomes. In the review, an increasing BMI was associated with increased rates of wound complications and prolonged hospital stay, but did not impact other surgical outcomes.Conclusion: Obesity is associated with increased rates of wound complications and a prolonged hospital stay, but does not appear to affect other operative outcomes including cytoreduction status and 30‐day mortality. Therefore, operative management and postoperative care require a multifactorial approach to minimise adverse outcomes.Tweetable Obesity is associated with more wound complications and prolonged hospital stay in ovarian cancer surgery.
- 2 September 2015
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 123 (2) , 300-308
Surgical morbidity and clinical outcomes in ovarian cancer – the role of obesity
Objective: To evaluate the effect of body mass index on the surgical outcomes in ovarian cancer patients. In addition, we performed a systematic review to compare our outcomes with the current literature.Design: Retrospective cohort study and a systematic review of the literature.Setting: Gynaecology department at the Royal Cornwall Hospital Trust.Population: Surgically managed stage I‐IV ovarian cancer patients between September 2006 and September 2014.Methods: Primary and secondary outcome measures were evaluated across BMI categories; BMI <25 kg/m², BMI 25–29.9 kg/m², BMI ≥30 kg/m² and BMI ≥40 kg/m². A systematic review was performed according to Preferred Reporting Items for Systematic reviews and Meta‐Analyses (PRISMA) guidelines.Main outcome measures: The primary outcome measure was surgical complications. Secondary outcome measures were other intra‐ and postoperative outcomes.Results: Two hundred twenty‐eight women were included in the study, of which 84 had a BMI <25 kg/m², 84 women had a BMI 25–29.9 kg/m², and 60 women were obese (BMI ≥30 kg/m²), 13 of whom were morbidly obese. Morbid obesity was associated with increased rates of wound complications. However, BMI did not show an association with other outcomes. In the review, an increasing BMI was associated with increased rates of wound complications and prolonged hospital stay, but did not impact other surgical outcomes.Conclusion: Obesity is associated with increased rates of wound complications and a prolonged hospital stay, but does not appear to affect other operative outcomes including cytoreduction status and 30‐day mortality. Therefore, operative management and postoperative care require a multifactorial approach to minimise adverse outcomes.Tweetable Obesity is associated with more wound complications and prolonged hospital stay in ovarian cancer surgery.
- 1 April 2015
- Published by Elsevier in Gynecologic Oncology
- Vol. 137 (1) , 180-187
Body mass index and the quality of life of endometrial cancer survivors—A systematic review and meta-analysis
- 1 April 2015
- Published by Elsevier in Gynecologic Oncology
- Vol. 137 (1) , 180-187
Body mass index and the quality of life of endometrial cancer survivors—A systematic review and meta-analysis
- 1 January 2014
- Published by Elsevier in Gynecologic Oncology
- Vol. 132 (1) , 137-141
The impact of BMI on quality of life in obese endometrial cancer survivors: Does size matter?
- 1 January 2014
- Published by Elsevier in Gynecologic Oncology
- Vol. 132 (1) , 137-141
The impact of BMI on quality of life in obese endometrial cancer survivors: Does size matter?
- 3 October 2013
- Published by Wiley
- No. 10
Recurrence after treatment (LLETZ) for cervical intraepithelial neoplasia (CIN): impact of human papillomavirus (HPV) test
- 3 October 2013
- Published by Wiley
- No. 10
Recurrence after treatment (LLETZ) for cervical intraepithelial neoplasia (CIN): impact of human papillomavirus (HPV) test
- 29 August 2013
- Published by Wiley
- No. 8
Surgery and chemotherapy with or without radiotherapy for disseminated advanced endometrial cancer
- 29 August 2013
- Published by Wiley
- No. 8
Surgery and chemotherapy with or without radiotherapy for disseminated advanced endometrial cancer